159 related articles for article (PubMed ID: 25868275)
61. Cholesterol shuttling is important for RNA replication of coxsackievirus B3 and encephalomyocarditis virus.
Albulescu L; Wubbolts R; van Kuppeveld FJ; Strating JR
Cell Microbiol; 2015 Aug; 17(8):1144-56. PubMed ID: 25645595
[TBL] [Abstract][Full Text] [Related]
62. Coxsackievirus B3 replication and pathogenesis.
Garmaroudi FS; Marchant D; Hendry R; Luo H; Yang D; Ye X; Shi J; McManus BM
Future Microbiol; 2015; 10(4):629-53. PubMed ID: 25865198
[TBL] [Abstract][Full Text] [Related]
63. Generation of a microRNA-Regulated Oncolytic Coxsackievirus B3.
Dieringer B; Elsner L; Hazini A; Kurreck J; Fechner H
Methods Mol Biol; 2022; 2521():259-282. PubMed ID: 35733003
[TBL] [Abstract][Full Text] [Related]
64. Mutation variants generated from nonvirulent coxsackievirus B3 acquire virulence phenotypes by active virus replication.
Seo I; Jee Y; Ahn J; Jun EJ; Kim D; Joo CH; Kim YK; Lee H
Intervirology; 2007; 50(6):447-53. PubMed ID: 18268408
[TBL] [Abstract][Full Text] [Related]
65. In vitro activity of Paris polyphylla smith against enterovirus 71 and coxsackievirus B3 and its immune modulation.
Wang YC; Yi TY; Lin KH
Am J Chin Med; 2011; 39(6):1219-34. PubMed ID: 22083992
[TBL] [Abstract][Full Text] [Related]
66. The stem loop II within the 5' nontranslated region of clinical coxsackievirus B3 genomes determines cardiovirulence phenotype in a murine model.
Dunn JJ; Bradrick SS; Chapman NM; Tracy SM; Romero JR
J Infect Dis; 2003 May; 187(10):1552-61. PubMed ID: 12721935
[TBL] [Abstract][Full Text] [Related]
67. Related Enteric Viruses Have Different Requirements for Host Microbiota in Mice.
Robinson CM; Woods Acevedo MA; McCune BT; Pfeiffer JK
J Virol; 2019 Dec; 93(23):. PubMed ID: 31511379
[TBL] [Abstract][Full Text] [Related]
68. Effect of verapamil on Ca2+ influx and CVB3-RNA replication in cultured neonatal rat heart cells infected with CVB3.
Yang Y; Guo Q; Peng T; Gu Q; Zhao J; Xiong D
Chin Med Sci J; 1996 Jun; 11(2):89-92. PubMed ID: 9387415
[TBL] [Abstract][Full Text] [Related]
69. Ubiquitination is required for effective replication of coxsackievirus B3.
Si X; Gao G; Wong J; Wang Y; Zhang J; Luo H
PLoS One; 2008 Jul; 3(7):e2585. PubMed ID: 18612413
[TBL] [Abstract][Full Text] [Related]
70. Coxsackievirus group B type 3 infection upregulates expression of monocyte chemoattractant protein 1 in cardiac myocytes, which leads to enhanced migration of mononuclear cells in viral myocarditis.
Shen Y; Xu W; Chu YW; Wang Y; Liu QS; Xiong SD
J Virol; 2004 Nov; 78(22):12548-56. PubMed ID: 15507642
[TBL] [Abstract][Full Text] [Related]
71. [MiR432* regulate the replication of coxsackievirus A16 in rhabdomyosarcoma cells].
Yang Z; Tien P
Wei Sheng Wu Xue Bao; 2014 Jun; 54(6):679-87. PubMed ID: 25272817
[TBL] [Abstract][Full Text] [Related]
72. Enteroviral Infection Inhibits Autophagic Flux via Disruption of the SNARE Complex to Enhance Viral Replication.
Mohamud Y; Shi J; Qu J; Poon T; Xue YC; Deng H; Zhang J; Luo H
Cell Rep; 2018 Mar; 22(12):3292-3303. PubMed ID: 29562184
[TBL] [Abstract][Full Text] [Related]
73. Mutational Disruption of cis-Acting Replication Element 2C in Coxsackievirus B3 Leads to 5'-Terminal Genomic Deletions.
Smithee S; Tracy S; Chapman NM
J Virol; 2015 Dec; 89(23):11761-72. PubMed ID: 26355088
[TBL] [Abstract][Full Text] [Related]
74. Sex-Dependent Intestinal Replication of an Enteric Virus.
Robinson CM; Wang Y; Pfeiffer JK
J Virol; 2017 Apr; 91(7):. PubMed ID: 28100612
[TBL] [Abstract][Full Text] [Related]
75. Coxsackievirus B3 infection induces changes in the expression of numerous piRNAs.
Yao H; Wang X; Song J; Wang Y; Song Q; Han J
Arch Virol; 2020 Jan; 165(1):105-114. PubMed ID: 31741095
[TBL] [Abstract][Full Text] [Related]
76. Coxsackievirus B3 infection induces cyr61 activation via JNK to mediate cell death.
Kim SM; Park JH; Chung SK; Kim JY; Hwang HY; Chung KC; Jo I; Park SI; Nam JH
J Virol; 2004 Dec; 78(24):13479-88. PubMed ID: 15564459
[TBL] [Abstract][Full Text] [Related]
77. Coxsackievirus B3 activates nuclear factor kappa B transcription factor via a phosphatidylinositol-3 kinase/protein kinase B-dependent pathway to improve host cell viability.
Esfandiarei M; Boroomand S; Suarez A; Si X; Rahmani M; McManus B
Cell Microbiol; 2007 Oct; 9(10):2358-71. PubMed ID: 17848167
[TBL] [Abstract][Full Text] [Related]
78. The inhibitory effect of astragalus membranaceus on coxsackie B-3 virus RNA replication.
Peng T; Yang Y; Riesemann H; Kandolf R
Chin Med Sci J; 1995 Sep; 10(3):146-50. PubMed ID: 8580483
[TBL] [Abstract][Full Text] [Related]
79. Coxsackievirus B infection induces the extracellular release of miR-590-5p, a proviral microRNA.
Germano JF; Sawaged S; Saadaeijahromi H; Andres AM; Feuer R; Gottlieb RA; Sin J
Virology; 2019 Mar; 529():169-176. PubMed ID: 30711774
[TBL] [Abstract][Full Text] [Related]
80. The role of autophagy during coxsackievirus infection of neural progenitor and stem cells.
Tabor-Godwin JM; Tsueng G; Sayen MR; Gottlieb RA; Feuer R
Autophagy; 2012 Jun; 8(6):938-53. PubMed ID: 22751470
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
